Serge Masson

ORCID: 0000-0002-1446-0281
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Synthesis and Reactivity of Sulfur-Containing Compounds
  • Cardiovascular Function and Risk Factors
  • Organophosphorus compounds synthesis
  • Synthesis of heterocyclic compounds
  • Sulfur-Based Synthesis Techniques
  • Sepsis Diagnosis and Treatment
  • Phosphorus compounds and reactions
  • Synthesis and Catalytic Reactions
  • Acute Myocardial Infarction Research
  • Cardiac Arrest and Resuscitation
  • Atrial Fibrillation Management and Outcomes
  • Organic Chemistry Cycloaddition Reactions
  • Synthesis and Characterization of Heterocyclic Compounds
  • Cardiac electrophysiology and arrhythmias
  • Cyclopropane Reaction Mechanisms
  • Cardiac pacing and defibrillation studies
  • Hormonal Regulation and Hypertension
  • Cardiac Fibrosis and Remodeling
  • Synthesis of Organic Compounds
  • Liver Disease Diagnosis and Treatment
  • Cardiac Imaging and Diagnostics
  • Biomarkers in Disease Mechanisms
  • Carbohydrate Chemistry and Synthesis
  • Asymmetric Synthesis and Catalysis

Roche (Switzerland)
2019-2024

Massachusetts General Hospital
2023

Harvard University
2023

Mario Negri Institute for Pharmacological Research
2012-2021

Istituti di Ricovero e Cura a Carattere Scientifico
1996-2021

Hospital de Sant Pau
2021

Istituto Nazionale di Fisica Nucleare, Sezione di Milano
2020

Ospedale Maggiore
2004-2015

Mario Negri Sud Foundation
2007-2015

Associazione Nazionale Medici Cardiologi Ospedalieri
2000-2015

Although previous studies have suggested the potential advantages of albumin administration in patients with severe sepsis, its efficacy has not been fully established.In this multicenter, open-label trial, we randomly assigned 1818 100 intensive care units (ICUs), to receive either 20% and crystalloid solution or alone. In group, target serum concentration was 30 g per liter more until discharge from ICU 28 days after randomization. The primary outcome death any cause at days. Secondary...

10.1056/nejmoa1305727 article EN New England Journal of Medicine 2014-03-18

Neurohormones are considered markers of heart failure progression. We examined whether changes in brain natriuretic peptide (BNP) and norepinephrine (NE) over time associated with corresponding mortality morbidity the Valsartan Heart Failure Trial.Plasma BNP NE were measured before randomization during follow-up approximately 4300 patients Trial. The relation between baseline all-cause first morbid event (M&M) was analyzed subgroups, values above below median, by quartiles. change percent...

10.1161/01.cir.0000054164.99881.00 article EN Circulation 2003-03-10

Circulating cardiac troponin T, a marker of cardiomyocyte injury, predicts adverse outcome in patients with heart failure (HF) but is detectable only small fraction those chronic stable HF. We assessed the prognostic value circulating T HF traditional (cTnT) and new precommercial highly sensitive assay (hsTnT).Plasma was measured 4053 enrolled Valsartan Heart Failure Trial (Val-HeFT). Troponin 10.4% population cTnT (detection limit < or = 0.01 ng/mL) compared 92.0% hsTnT (< 0.001 ng/mL)....

10.1161/circulationaha.106.655076 article EN Circulation 2007-08-14

Background— The role of C-reactive protein (CRP) in heart failure is not well studied. We assessed the prognostic value CRP patients randomized Val-HeFT (Valsartan Heart Failure Trial) and studied changes that were associated with valsartan. Methods Results— Characteristics baseline levels above below median compared. Univariable multivariable Cox proportional hazards regression models used to examine relationship mortality morbidity. Interactions tested determine whether differences from 4...

10.1161/circulationaha.104.508465 article EN Circulation 2005-08-30

Background: The B-type or brain natriuretic peptides (BNP) and the amino-terminal probrain peptide (NT-proBNP) are good markers of prognosis diagnosis in chronic heart failure (HF). It is unclear, however, whether differences their biological characteristics modify clinical correlates prognostic performance HF. This work aimed to provide a direct comparison value BNP NT-proBNP patients with stable Methods: We measured at baseline 3916 enrolled Valsartan Heart Failure Trial. To identify...

10.1373/clinchem.2006.069575 article EN Clinical Chemistry 2006-06-16

Rationale: Unphysiologic strain (the ratio between tidal volume and functional residual capacity) stress transpulmonary pressure) can cause ventilator-induced lung damage.Objectives: To identify a strain–stress threshold (if any) above which damage occur.Methods: Twenty-nine healthy pigs were mechanically ventilated for 54 hours with producing 0.45 3.30. Ventilator-induced was defined as net increase in weight.Measurements Main Results: Initial weight capacity measured computed tomography....

10.1164/rccm.201010-1757oc article EN American Journal of Respiratory and Critical Care Medicine 2011-02-05

Objective: Tidal volume (VT) and of gas caused by positive end-expiratory pressure (VPEEP) generate dynamic static lung strains, respectively. Our aim was to clarify whether different combinations resulting in the same large global strain, constantly produce edema. Design: Laboratory investigation. Setting: Animal unit. Subjects: Twenty-eight healthy pigs. Interventions: After computed tomography, 20 animals were ventilated for 54 hours at a strain 2.5, either entirely (VT 100% VPEEP 0%),...

10.1097/ccm.0b013e31827417a6 article EN Critical Care Medicine 2013-02-05

Abstract Introduction Sepsis, a leading cause of death in critically ill patients, is the result complex interactions between infecting microorganisms and host responses that influence clinical outcomes. We evaluated prognostic value presepsin (sCD14-ST), novel biomarker bacterial infection, compared it with procalcitonin (PCT). Methods This retrospective, case–control study multicenter, randomized trial enrolling patients severe sepsis or septic shock ICUs Italy. selected 50 survivors...

10.1186/cc13183 article EN cc-by Critical Care 2014-01-07
Daniela Cardinale Fabio Ciceri Roberto Latini Maria Grazia Franzosi Maria Teresa Sandri and 95 more Maurizio Civelli G Cucchi E. Menatti Maurizio Mangiavacchi Raffaele Cavina Enrico Barbieri Stefania Gori Alessandro Colombo Giuseppe Curigliano Michela Salvatici A Rizzo Francesco Ghisoni Alessandra Bianchi Cristina Falci Michele Aquilina Andrea Rocca Anna Monopoli Carlo Milandri Giuseppe Rossetti Marco Bregni Marco Sicuro Alessandra Malossi Daniele Nassiacos Claudio Verusio Monica Giordano Lidia Staszewsky Simona Barlera Enrico Nicolis Michela Magnoli Serge Masson Carlo M. Cipolla Carlo M. Cipolla Daniela Cardinale Fabio Ciceri Roberto Latini Maria Teresa Sandri Aldo P. Maggioni Roberto Labianca Mauro Tettamanti Michele Senni A Finzi Federica Grosso Tarcisio Vago Maurizio Civelli Silvana Gramenzi Serge Masson Giovanna Balconi Roberto Bernasconi Michela Salvatici Enrico Nicolis Simona Barlera Matteo Magnoli Marc Buratti Luisa Ojeda‐Fernández Maria Grazia Franzosi Lidia Staszewsky Antonella Vasamì Alessandra Malossi Marco Sicuro B. Thiebat Catherine V. Bare Alessandro Corzani Fabio Coccolo S. Colecchia Carlo Pellegrini Marco Bregni L. Appio I. Caico G. Rossetti O. Mesenzani Camila Sato Campana Monica Giordano Mónica B. Gilardoni Giancarlo Scognamiglio Giacomo Corrado D. Battagin Fabrizio De Rosa C. Carpino S. Palazzo Anna Monopoli Carlo Milandri Piergiorgio Giannessi G. Zipoli Francesco Ghisoni A Rizzo Paolo Pastori Simona Callegari C. Sesenna Antonio Colombo Giuseppe Curigliano Cristiana Fodor Maurizio Mangiavacchi Raffaele Cavina D. Guiducci Rita Mazza

10.1016/j.ejca.2018.02.005 article EN European Journal of Cancer 2018-03-20

Background— Brain natriuretic peptide (BNP) and norepinephrine (NE) are strongly related to severity of independent predictors outcome in heart failure. The long-term effects angiotensin receptor blockers on BNP NE failure patients not known. Methods Results— Both were measured 4284 randomized valsartan or placebo the Valsartan Heart Failure Trial (Val-HeFT) at baseline 4, 12, 24 months after randomization. tested by ANCOVA, controlling for values concomitant ACE inhibitors and/or...

10.1161/01.cir.0000036747.68104.ac article EN Circulation 2002-11-04

Cardiac troponins are emerging as important prognostic markers in chronic cardiovascular conditions like stable coronary artery disease or heart failure (HF). Less is known about the relation between serial measurements of high-sensitivity cardiac troponin T (hs-cTnT) and future events HF. We determined association changes over time hs-cTnT outcome patients with HF.We analyzed 5284 HF from 2 independent randomized clinical trials, Valsartan Heart Failure Trial (Val-HeFT) (n=4053) Gruppo...

10.1161/circulationaha.111.044149 article EN Circulation 2011-12-03

Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even the presence of normal filtration. We studied relationship between tubular filtration, excretion, HF patients. In 2130 participating GISSI-HF trial, we measured albumin-to-creatinine ratio (UACR), estimated rate (eGFR), three markers damage: N-acetyl-beta-d-glucosaminidase...

10.1093/eurheartj/ehr190 article EN European Heart Journal 2011-06-11

Abstract Septic shock remains a major problem in Intensive Care Unit, with high lethality and high-risk second lines treatments. In this preliminary retrospective investigation we examined plasma metabolome clinical features subset of 20 patients severe septic (SOFA score &gt;8), enrolled the multicenter Albumin Italian Outcome Sepsis study (ALBIOS, NCT00707122). Our purpose was to evaluate changes circulating metabolites relation mortality as pilot be extended larger cohort. Patients were...

10.1038/srep20391 article EN cc-by Scientific Reports 2016-02-05

Background— We developed a prognostic model to assess the risk of all-cause mortality in patients with chronic heart failure. Methods and Results— examined 6975 failure enrolled Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure (GISSI-HF) trial (3.9 years follow-up). Multivariable Cox regression models were predict (1969 deaths). By stepwise selection, full final included 25 predictors. A reduced model, considering most significant variables ranked...

10.1161/circheartfailure.112.967828 article EN Circulation Heart Failure 2012-11-15

The renin-angiotensin system (RAS) plays a role in the pathogenesis of ARDS, Angiotensin II (Ang-II) contributing to inflammation and fibrogenesis. Angiotensin-(1-7) (Ang-(1-7)) may antagonize effects Ang-II. This study was aimed at evaluating potential for Ang-(1-7) reduce injury, fibrosis an experimental model ARDS acute late phases.Male Sprague Dawley rats underwent instillation 0.1 M hydrochloric acid (HCl, 2.5 ml/kg) into right bronchus. In study, acid-injured were subjected high...

10.1186/s40635-015-0044-3 article EN cc-by Intensive Care Medicine Experimental 2015-02-26
Coming Soon ...